High-throughput screening for modulators of cellular contractile force.

Area of Science:

• Biomedical Engineering
• Pharmacology
• Cell Biology

Background:

• Cellular contractile forces play a key role in diseases like asthma and glaucoma.
• Current drug screening methods often target upstream signaling molecules, not the direct cellular forces involved in disease.

Purpose of the Study:

• To develop and validate a new high-throughput screening technology to directly measure cellular forces.
• To identify potential drug candidates for asthma and glaucoma using this novel force-based screening platform.

Main Methods:

• Developed a high-throughput screening technology focused on cellular contractile forces.
• Applied the technology to human airway smooth muscle cells (asthma model) and Schlemm's canal endothelial cells (glaucoma model).
• Achieved screening rates of 1000 compounds per day.

Main Results:

• Successfully identified several promising drug candidates for both asthma and glaucoma.
• Demonstrated the feasibility and efficiency of the force-based cellular platform for drug discovery.
• Established a new paradigm for targeting cellular forces in therapeutic development.

Conclusions:

• The developed force-based screening platform is effective for high-throughput drug discovery.
• This technology offers a more direct approach to targeting cellular forces in disease treatment.
• The identified drug candidates warrant further investigation for asthma and glaucoma therapies.